S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Nu Skin Enterprises To Report Second-Quarter 2014 Results|
|Syneron Receives China CFDA Clearance for elure™ Advanced Skin Brightening Lotion|
|Cubist’s SIVEXTRO™ (tedizolid phosphate) Approved in U.S. to Treat Serious Skin Infections—Including Those Caused by MRSA|
|Dipexium Pharmaceuticals Announces Successful Completion of Phase 1 Skin Irritation Trial of Locilex®|
|Lourdes Specialty Hospital Receives 3M Award for Excellence in Skin Safety at 46th Annual Conference of the Wound, Ostomy and Continence Nurses Society (2014/6/23)|
|AbbVie Announces Pivotal Phase 3 Data Evaluating Efficacy of HUMIRA® (adalimumab) in Patients with Hidradenitis Suppurativa (HS), a Chronic Inflammatory Skin Disease|
|Olay Hosts Ultimate Before-and-After Skin Care Challenge (2014/7/8)|
|The Cetaphil® Brand Unveils New Limited-Edition Moisturizing Cream Available Exclusively at CVS/pharmacy in Support of Camp Wonder (2014/8/6)|
|July is UV Safety Month (2014/7/2)|
|Cubist’s Once-daily SIVEXTRO™ (tedizolid phosphate) Available for Physician and Hospital Order in I.V. and Oral Formulations|
Click above to view more mutual fund data and stats for skin - Skinovation Pharmaceutical Inc.